Status:
RECRUITING
Prevalence of Amyloidosis in Trauma Patients
Lead Sponsor:
Consorci Sanitari de l'Alt Penedès i Garraf
Conditions:
Amyloidosis
Eligibility:
All Genders
Brief Summary
This study aims to determine the frequency of amyloidosis among patients undergoing trauma surgery.
Eligibility Criteria
Inclusion
- Men and women included in the waiting list for scheduled trauma surgery with at least one of the following criteria defined as red flags: Over 65 years old; Possible family history of amyloidosis, Cardiac pathology: aortic stenosis, presence of left ventricular hypertrophy defined as interventricular septal thickness \> 12mm measured by echocardiography, history of previous brady- or tachyarrhythmias including cardiac conduction blocks, history of syncope or presyncope, pro BNP \> 300 in previous blood tests; History of sensory peripheral neuropathy; History of nephropathy without etiological diagnosis; History of liver disease without a clear cause.
- Ability to cooperate in the necessary evaluations.
- Signed informed consent for inclusion in the study, either by the participant or their legal representative.
Exclusion
- \- Participants previously diagnosed with amyloidosis cannot be included in the study.
Key Trial Info
Start Date :
November 13 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
246 Patients enrolled
Trial Details
Trial ID
NCT06527521
Start Date
November 13 2024
End Date
October 1 2026
Last Update
December 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Consorci Sanitari Alt Penedes i Garraf-Hospital Sant Camil
Sant Pere de Ribes, Barcelona, Spain, 08810